A multicenter record review of in-hospital adverse drug events requiring a higher level of care

References

• Battles JB, Lilford RJ. Organizing patient safety research to identify risks and hazards. Qual Saf Health Care. 2003;12(Suppl 2):ii2–7.
   PubMedGoogle Scholar
• de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17:216–223.10.1136/qshc.2007.023622
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US). Institute of Medicine (US) Committee on Quality of Health Care in America. To err is human: building a safer health system. Washington (DC): National Academies Press (US); 2000.
   Google Scholar
• Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for Prevention. JAMA. 1995;274:29–34.
   PubMed Web of Science ®Google Scholar
• Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. JAMA. 1995;274:35–43.10.1001/jama.1995.03530010049034
   PubMed Web of Science ®Google Scholar
• Aljadhey H, Mahmoud MA, Mayet A, Alshaikh M, Ahmed Y, Murray MD, et al. Incidence of adverse drug events in an academic hospital: a prospective cohort study. Int J Qual Health Care. 2013;25:648–655.10.1093/intqhc/mzt075
   PubMed Web of Science ®Google Scholar
• Hug BL, Witkowski DJ, Sox CM, Keohane CA, Seger DL, Yoon C, et al. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention. J Gen Intern Med. 2010;25:31–38.10.1007/s11606-009-1141-3
   PubMed Web of Science ®Google Scholar
• Morimoto T, Sakuma M, Matsui K, Kuramoto N, Toshiro J, Murakami J, et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Intern Med. 2011;26:148–153.10.1007/s11606-010-1518-3
   PubMed Web of Science ®Google Scholar
• Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–2018.10.1001/archinte.163.17.2014
   PubMedGoogle Scholar
• Leape LL, Brennan T, Laird N, Lawthers A, Localio A, Barnes B, et al. The nature of adverse events in hospitalized patients. N Engl J Med. 1991;324:377–384.10.1056/NEJM199102073240605
   PubMed Web of Science ®Google Scholar
• Gandhi TK, Seder DL, Bates DW. Methodology matters. identifying drug safety issues: from research to practice. Int J Qual Health Care. 2000;12:69–76.10.1093/intqhc/12.1.69
   PubMed Web of Science ®Google Scholar
• Benkirane RR, R-Abouqal R, Haimeur C, S.Ech.Cherif El Kettani S, Azzouzi AA, M’daghri Alaoui AA, et al. Incidence of adverse drug events and medication errors in intensive care units. J Patient Saf. 2009;5:16–22.10.1097/PTS.0b013e3181990d51
   PubMedGoogle Scholar
• Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–306.10.1001/jama.1997.03540280039031
   PubMed Web of Science ®Google Scholar
• von Laue NC, Schwappach DLB, Koeck CM. The epidemiology of preventable adverse drug events: A review of the literature. Wien Klin Wochenschr. 2003;115:407–415.10.1007/BF03040432
   PubMed Web of Science ®Google Scholar
• Kunac D, Kennedy J, Austin N, Reith D. Incidence, preventability, and impact of adverse drug events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study. Paediatr Drugs. 2009;11:153–160.10.2165/00148581-200911020-00005
   PubMedGoogle Scholar
• Jolivot P-A, Pichereau C, Hindlet P, Hejblum G, Bigé N, Maury E, et al. An observational study of adult admissions to a medical ICU due to adverse drug events. Ann Intensive Care. 2016;6:9–20.10.1186/s13613-016-0109-9
   PubMed Web of Science ®Google Scholar
• Damen NL, Baines R, Wagner C, Langelaan M. Medication-related adverse events during hospitalization: a retrospectuive patient record review study in The Netherlands. Pharmacoepidemiol Drug Saf. 2016;10:4037.
   Google Scholar
• Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(90001):49i–59.10.1093/intqhc/mzg085
   Web of Science ®Google Scholar
• Swann D, Houston P, Goldberg J. Audit of intensive care unit admissions from the operating room. Can J Anaesth. 1993;40:137–141.10.1007/BF03011311
   PubMed Web of Science ®Google Scholar
• Hoonhout LHF, de Bruijne MC, Wagner C, Asscheman H, der Wal G, van Tulder MW. Nature, occurrence and consequences of medication – related adverse events during hospitalization. Drug Saf. 2010;33:853–864.10.2165/11536800-000000000-00000
   PubMed Web of Science ®Google Scholar
• Mercier E, Giraudeau B, Giniès G, Perrotin D, Dequin P-F. Iatrogenic events contributing to ICU admission: a prospective study. Intensive Care Med. 2010;36:1033–1037.10.1007/s00134-010-1793-9
   PubMed Web of Science ®Google Scholar
• Garry DA, McKechnie SR, Culliford DJ, Ezra M, Garry PS, Loveland RC, et al. A prospective multicentre observational study of adverse iatrogenic events and substandard care preceding intensive care unit admission (PREVENT). Anaesthesia. 2014;69:137–142.10.1111/anae.2014.69.issue-2
   PubMed Web of Science ®Google Scholar
• Lehmann LS, Puopolo AL, Shaykevich S, Brennan TA. Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions. Am J Med. 2005;118:409–413.10.1016/j.amjmed.2005.01.012
   PubMed Web of Science ®Google Scholar
• Jolivot P-A, Hindlet P, Pichereau C, Fernandez C, Maury E, Guidet B, et al. A systematic review of adult admissions to ICUs related to adverse drug events. Crit Care. 2014;18:1017–659.10.1186/s13054-014-0643-5
   Web of Science ®Google Scholar
• Grenouillet-Delacre M, Verdoux H, Moore N, Haramburu F, Miremont-Salamé G, Etienne G, et al. Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med. 2007;33:2150–2157.10.1007/s00134-007-0787-8
   PubMed Web of Science ®Google Scholar
• Vlayen A, Marquet K, Schrooten W, Vleugels A, Hellings J, De Troy E, et al. Design of a medical record review study on the incidence and preventability of adverse events requiring a higher level of care in Belgian hospitals. BMC Res Notes. 2012;5:468–476.10.1186/1756-0500-5-468
   PubMedGoogle Scholar
• OpenClinica. [cited 2016 Oct 30]. Available from https://community.openclinica.com/
   Google Scholar
• Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–284.10.1097/00000542-194105000-00004
   Google Scholar
• Anesthesiologists ASo. New classification of physical status. Anesthesiology. 1963;24:111.
   Google Scholar
• Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The quality in Australian health care study. Med J Aust. 1995;163:458–471.
   PubMed Web of Science ®Google Scholar
• Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, et al. The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada. CMAJ. 2004;170:1678–1686.10.1503/cmaj.1040498
   PubMed Web of Science ®Google Scholar
• Zegers M, de Bruijne MC, Wagner C, Groenewegen PP, Waaijman R, van der Wal G. Design of a retrospective patient record study on the occurrence of adverse events among patients in Dutch hospitals. BMC Health Serv Res. 2007;7:1678–37.10.1186/1472-6963-7-27
   Web of Science ®Google Scholar
• Jha A, Kuperman G, Teich J, Leape L, Shea B, Rittenberg E, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inf Assoc. 1998;5:305–314.10.1136/jamia.1998.0050305
   PubMed Web of Science ®Google Scholar
• Otero M-J, Schmitt E. Clarifying terminology for adverse drug events. Ann Intern Med. 2005;142:77–78.10.7326/0003-4819-142-1-200501040-00016
   PubMed Web of Science ®Google Scholar
• Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: A clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140:795–801.10.7326/0003-4819-140-10-200405180-00017
   PubMed Web of Science ®Google Scholar
• WHO collaborating centre for drug statistics methodoly. [cited 2016 Oct 30]. Available from: http://www.whocc.no/atc_ddd_index/
   Google Scholar
• Agentschap Zorg en Gezondheid [Agency for Care and Health]. [cited 2016 Oct 30]. Available from: www.zorg-en-gezondheid.be/zorgaanbod.
   Google Scholar
• Kruispuntbank van de Sociale Zekerheid en eHealth-platform [Privacy Commission]. [cited 2016 Oct 30]. Available from: https://www.ksz-bcss.fgov.be/
   Google Scholar
• Marquet K, Claes N, De Troy E, Kox G, Droogmans M, Schrooten W, et al. One fourth of unplanned transfers to a higher level of care are associated with a highly preventable adverse event. Crit. Care Med. 2015;43(5):1053–1061.10.1097/CCM.0000000000000932
   PubMed Web of Science ®Google Scholar
• Marquet K, Liesenborgs A, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Critical Care. 2015;19(1):63–74.10.1186/s13054-015-0795-y
   PubMed Web of Science ®Google Scholar